August 22, 2016 by Chain Drug Review
American Journal of Managed Care, Care 1-on-1, CVS Caremark, CVS Health, CVS Health Research Institute, Jonathan Roberts, medication adherence, pharmacy benefit management, Troyen Brennan
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — Interventions that keep chronic disease patients on their medications are “extraordinarily cost-effective,” according to CVS Health. CVS said Monday that a new study from the CVS Health Research Institute, published in The American Journal of Managed Care, also found a greater opportunity for savings if medication adherence resources focus on patients with
February 22, 2016 by Brian Bossetta and Chain Drug Review
Alan Lotvin, CVS Health, CVS Health Research Institute, CVS/specialty, Specialty Connect, specialty pharmacy, William Shrank
2016, Issue 02-22-2016, Issues, News
WOONSOCKET, R.I. — New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s specialty prescription services program. New patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and existing
January 29, 2016 by Chain Drug Review
Alan Lotvin, CVS Health, CVS Health Research Institute, CVS Specialty, Specialty Connect, specialty drug, specialty pharmacy, William Shrank
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — CVS Health found that patients in a pilot study of its Specialty Connect specialty drug program had a significant improvement in adherence to their medication. CVS said Friday that new patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and current specialty patients had an 11.4
September 28, 2015 by Mark Baumgartner and Chain Drug Review
CVS Health, CVS Health Research Institute, medication adherence, narrow pharmacy networks, William Shrank
2015, Issue 09-28-2015, Issues, News
WOONSOCKET, R.I. — A CVS Health Research Institute review of pharmacy claims for more than 200,000 patients found an association between narrow pharmacy networks and improved medication adherence. The study was the first to evaluate the impact of narrow pharmacy networks — which incentivize plan members to use in-network pharmacies — on medication adherence. Such
September 21, 2015 by Chain Drug Review
Brigham and Women's Hospital, CVS Health, CVS Health Research Institute, medication adherence, Niteesh Choudhry, William Shrank
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — The first prescriptions filled by patients with chronic conditions provide a good sign of how well they will adhere to their medications, according to research by CVS Health. CVS said Monday that a new study by the CVS Health Research Institute and Brigham and Women’s Hospital revealed that patients’ patterns of medication
September 14, 2015 by Geoff Walden and Chain Drug Review
cigarette purchases, CVS Health, CVS Health Foundation, CVS Health Research Institute, CVS/pharmacy, CVS/pharmacy’s tobacco removal, Eileen Howard Boone, smoking cessation, tobacco sales, Troy Brennan
2015, Issue 09-14-2015, Issues, News
WOONSOCKET, R.I. — Cigarette purchases across the retail spectrum have declined measurably in the year since CVS/pharmacy banned tobacco sales, CVS Health reported this month. “One year ago, we stopped selling tobacco products because it conflicted with our purpose of helping people on their path to better health,” said CVS Health chief medical officer Dr.
September 8, 2015 by Chain Drug Review
CVS Health, CVS Health Research Institute, CVS/caremark, drug benefit plans, medication adherence, narrow pharmacy networks, preferred pharmacies, prescription drug coverage, William Shrank
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — Members of drug benefit plans with narrow pharmacy networks show improved medication adherence, according to a new study by the CVS Health Research Institute. CVS Health said Tuesday that the research, published in JAMA Internal Medicine, is the first to gauge the impact of narrow pharmacy networks on medication adherence. Narrow networks
September 3, 2015 by Chain Drug Review
cigarette purchases, CVS Health, CVS Health Foundation, CVS Health Research Institute, CVS/pharmacy, Eileen Howard Boone, nicotine replacement therapy, smoking cessation, tobacco products, tobacco sales, Troy Brennan
Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. — CVS/pharmacy’s removal of tobacco products from its stores is showing its impact a year later. A study by the CVS Health Research Institute revealed a reduction in cigarette purchases over the past year, CVS Health said Thursday. Evaluating cigarette pack purchases at drug, food, big-box, dollar, convenience and gas station retailers in the
August 22, 2015 by Scot Meyer and Chain Drug Review
cholesterol management guidelines, cholesterol-lowering medications, CVS Health, CVS Health Research Institute, PCSK9 inhibitors, Troyen Brennan, William Shrank
2015, Issue 08-24-2015, Issues, News
WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known
August 10, 2015 by Chain Drug Review
American College of Cardiology/American Heart Association, CVS Health Research Institute, Journal of the American Medical Association, management of high cholesterol, PCSK9 inhibitors, Praluent, Troy Brennan, William Shrank
Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute. In a commentary published online Monday in the Journal of the American Medical Association (JAMA), the CVS Health experts said that as PCSK9 inhibitors — a new
May 14, 2015 by Chain Drug Review
700 Good Reasons, CVS Health, CVS Health Research Institute, Lisa Bisaccia, Perelman School of Medicine, smoking cessation, smoking cessation programs, Stop to Start, Troyen Brennan
Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. — Next month, CVS Health plans to launch an employee smoking cessation program that reflects the findings of new research and continues the company’s efforts to reduce tobacco use. According to a study by the CVS Health Research Institute and researchers from the University of Pennsylvania’s Perelman School of Medicine, employer-sponsored smoking cessation programs that offer financial incentives show higher